Chinese Sinopharm COVID vaccine effective in older people Moroccan health ministry
2021-02-09 13:58
A booth displaying a coronavirus vaccine candidate from China National Biotec Group CNBG, a unit of stateowned pharmaceutical giant China National Pharmaceutical Group Sinopharm, is seen at the  China International Fair for Trade in Services CIFTIS, following the COVID outbreak, in Beijing, China Sept , . PhotoAgencies    RABAT  The Chinese Sinopharm vaccine is effective in older people and Morocco will continue using it to vaccinate the population aged  and over, authorities said Monday. Available data from the Moroccan vaccination campaign showed no increase in adverse effects on the vaccinated people aged  and over compared with others receiving the Sinopharm vaccine, Moroccan Health Ministry said in a statement. So far, only eight people in this age group have reported minor adverse effects after receiving Sinopharm doses, which is equivalent to . cases per ,, it said. A phase III clinical trial of the Sinopharm vaccine, partly carried out in Morocco, included people aged  and over and showed good tolerance in this population, the statement said. The phase III clinical trial showed an overall efficacy of  percent and good safety, it added. Morocco launched a nationwide vaccination campaign at , locations on Jan.  after securing acquisition of  million doses of COVID vaccines from Chinas Sinopharm and Britains Oxford University and AstraZeneca.